Posted by Michael Wonder on 13 Dec 2025
PBAC weight loss drug decision imminent
12 December 2025 - Patients are spending as much as $5,000/year on private market GLP-1 therapies – an incoming PBAC recommendation could change that.
A long-awaited decision on whether weight-loss drugs should be included on the PBS is expected to be handed down in a matter of weeks, the Health Minister says.
